104 related articles for article (PubMed ID: 12127689)
1. Effect of combined photodynamic and chemotherapeutic treatment on lymphoma cells in vitro.
Nonaka M; Ikeda H; Inokuchi T
Cancer Lett; 2002 Oct; 184(2):171-8. PubMed ID: 12127689
[TBL] [Abstract][Full Text] [Related]
2. Subcellular localization of Photofrin determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets.
Hsieh YJ; Wu CC; Chang CJ; Yu JS
J Cell Physiol; 2003 Mar; 194(3):363-75. PubMed ID: 12548556
[TBL] [Abstract][Full Text] [Related]
3. The role of the p53 tumor suppressor in the response of human cells to photofrin-mediated photodynamic therapy.
Tong Z; Singh G; Rainbow AJ
Photochem Photobiol; 2000 Feb; 71(2):201-10. PubMed ID: 10687395
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of heat shock protein 70 on apoptosis induced by photodynamic therapy in vitro.
Nonaka M; Ikeda H; Inokuchi T
Photochem Photobiol; 2004 Jan; 79(1):94-8. PubMed ID: 14982037
[TBL] [Abstract][Full Text] [Related]
5. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
6. Combination with genistein enhances the efficacy of photodynamic therapy against human anaplastic thyroid cancer cells.
Ahn JC; Biswas R; Chung PS
Lasers Surg Med; 2012 Dec; 44(10):840-9. PubMed ID: 23143780
[TBL] [Abstract][Full Text] [Related]
7. Large mutagenic lesions are induced by photodynamic therapy in murine L5178Y lymphoblasts.
Deahl JT; Oleinick NL; Evans HH
Photochem Photobiol; 1993 Aug; 58(2):259-64. PubMed ID: 8415919
[TBL] [Abstract][Full Text] [Related]
8. Enhanced susceptibility of mouse squamous cell carcinoma to photodynamic therapy combined with low-dose administration of cisplatin.
Uehara M; Inokuchi T; Ikeda H
J Oral Maxillofac Surg; 2006 Mar; 64(3):390-6. PubMed ID: 16487799
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy.
Domagala A; Stachura J; Gabrysiak M; Muchowicz A; Zagozdzon R; Golab J; Firczuk M
BMC Cancer; 2018 Feb; 18(1):210. PubMed ID: 29463237
[TBL] [Abstract][Full Text] [Related]
10. Changes in intracellular Ca2+ concentrations related to PDT-induced apoptosis in photosensitized human cancer cells.
Tajiri H; Hayakawa A; Matsumoto Y; Yokoyama I; Yoshida S
Cancer Lett; 1998 Jun; 128(2):205-10. PubMed ID: 9683284
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of photodynamic therapy by mitomycin C in cultured human colon adenocarcinoma cells.
Ma LW; Moan J; Berg K; Peng Q; Steen HB
Radiat Res; 1993 Apr; 134(1):22-8. PubMed ID: 8475251
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis of gastric cancer cell line MKN45 by photodynamic treatment with photofrin.
Takahira K; Sano M; Arai H; Hanai H
Lasers Med Sci; 2004; 19(2):89-94. PubMed ID: 15338443
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
14. Increased tumour dihydroceramide production after Photofrin-PDT alone and improved tumour response after the combination with the ceramide analogue LCL29. Evidence from mouse squamous cell carcinomas.
Separovic D; Bielawski J; Pierce JS; Merchant S; Tarca AL; Ogretmen B; Korbelik M
Br J Cancer; 2009 Feb; 100(4):626-32. PubMed ID: 19223911
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen increases photodynamic therapeutic response of U87 and U25ln human glioma cells.
Jiang F; Cho KK; Mikkelse T; Tong L; Lew YS; Hochbaum N; Shargorodsky J; Chop M
J Neurooncol; 2002 Jan; 56(1):51-8. PubMed ID: 11949827
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial alterations in photodynamic therapy-resistant cells.
Sharkey SM; Wilson BC; Moorehead R; Singh G
Cancer Res; 1993 Oct; 53(20):4994-9. PubMed ID: 8402690
[TBL] [Abstract][Full Text] [Related]
17. Molecular determinants of photodynamic therapy for lung cancers.
Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Maehara S; Imai K; Shima K; Ohira T; Kato H; Ikeda N
Lasers Surg Med; 2011 Sep; 43(7):591-9. PubMed ID: 22057486
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors.
Ferrario A; Fisher AM; Rucker N; Gomer CJ
Cancer Res; 2005 Oct; 65(20):9473-8. PubMed ID: 16230411
[TBL] [Abstract][Full Text] [Related]
19. Relation of early Photofrin uptake to photodynamically induced phototoxicity and changes of cell volume in different cell lines.
Leunig A; Staub F; Peters J; Heimann A; Csapo C; Kempski O; Goetz AE
Eur J Cancer; 1994; 30A(1):78-83. PubMed ID: 8142170
[TBL] [Abstract][Full Text] [Related]
20. Single cell FRET imaging for determination of pathway of tumor cell apoptosis induced by photofrin-PDT.
Wu Y; Xing D; Chen WR
Cell Cycle; 2006 Apr; 5(7):729-34. PubMed ID: 16627992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
